They contain unique anti-inflammatory compounds that may help with everything from joint pain to better sleep
Prolia (denosumab) Disease area(s): Bone health Manufacturer(s): Amgen 2024 Sales (USD): $4.37 billion Why it sold so well: In 2024, Amgens Prolia achieved strong sales, with global revenues increasing by 8% year-over-year to $4.37 billion for the year, driven primarily by volume growth
On this episode of unPAUSED, @drsalaswhalen and I discuss how these medications fit into a comprehensive plan that looks at body composition, hormones, and each patients unique health journey
The bacterial colonies stabilize
Preferred in bodybuilding communities for theoretical local growth enhancement, though site-specific effects are debated
However, studies that describe how the oxidative stress is involved in disease development remain insufficient